Calls to Pharmac to fund a life extending drug for those with lung cancer

Keytruda's been labelled a miracle drug and funded for people with melanoma but it isn't funded for people with lung cancer.

Father of three Baden Ngan Kee pays eight thousand dollars every three weeks for the drug that he says is keeping him alive.

He says research shows Keytruda could be just as successful for lung cancer, as it is for melanoma.

Kee believes that in time, it could be a universal drug that could apply to a number of cancers.